Irie A, Fukui T, Negishi M, Nagata N, Ichikawa A
Department of Physiological Chemistry, Faculty of Pharmaceutical Sciences, Kyoto University, Japan.
Biochim Biophys Acta. 1992 Nov 20;1160(2):229-34. doi: 10.1016/0167-4838(92)90012-3.
A binding protein which exhibits high affinity to [3H]glycyrrhetinic-acid in the rat liver microsomal fraction was solubilized with 0.2% Triton DF-18 and then purified to homogeneity. The equilibrium dissociation constant of the [3H]glycyrrhetinic-acid binding reaction and the maximal concentration for the binding of the purified protein, as determined by Scatchard plot analysis, were 27.6 nM and 7.79 nmol/mg protein, respectively. The molecular mass of the subunit (34 kDa) and 30 amino acids of N-terminal sequence of the purified protein were entirely the same as those of the reported 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD). In each purification step, the recovery and purification (fold) of the glycyrrhetinic-acid binding activity corresponded to the values of 11 beta-HSD activity. These results show that the purified [3H]glycyrrhetinic-acid binding protein is 11 beta-HSD. From the molecular mass of 11 beta-HSD (135 kDa) and the maximal concentration of the binding site, it was calculated that one glycyrrhetinic acid molecule binds to one 11 beta-HSD molecule. The inhibitory effects of various glycyrrhetinic-acid derivatives on [3H]glycyrrhetinic acid binding and 11 beta-HSD activity indicate that the C30-carboxyl and C11-carbonyl groups of glycyrrhetinic acid are the principal structures for the 11 beta-HSD inhibition.
一种对大鼠肝微粒体组分中的[3H]甘草次酸具有高亲和力的结合蛋白,用0.2% Triton DF - 18进行增溶,然后纯化至同质。通过Scatchard作图分析确定,[3H]甘草次酸结合反应的平衡解离常数和纯化蛋白结合的最大浓度分别为27.6 nM和7.79 nmol/mg蛋白。纯化蛋白亚基的分子量(34 kDa)和N端序列的30个氨基酸与报道的11β - 羟基类固醇脱氢酶(11β - HSD)完全相同。在每个纯化步骤中,甘草次酸结合活性的回收率和纯化倍数(纯化程度)与11β - HSD活性的值相对应。这些结果表明,纯化的[3H]甘草次酸结合蛋白就是11β - HSD。根据11β - HSD的分子量(135 kDa)和结合位点的最大浓度计算得出,一个甘草次酸分子与一个11β - HSD分子结合。各种甘草次酸衍生物对[3H]甘草次酸结合和11β - HSD活性的抑制作用表明,甘草次酸的C30 - 羧基和C11 - 羰基是抑制11β - HSD的主要结构。